Corcept Therapeutics (CORT) Change in Cash (2010 - 2026)

Corcept Therapeutics has disclosed Change in Cash across 17 years of filings, most recently posting -$11.8 million for Q1 2026.

• Change in Cash for Q1 2026 came in at -$11.8 million, up 68.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.9 million (up 131.57% YoY), and the FY2025 annual result was -$7.2 million, up 9.08% from the prior year.
• Change in Cash came in at -$11.8 million for Q1 2026 at Corcept Therapeutics, down from -$4.6 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $233.6 million in Q1 2023 to a low of -$127.6 million in Q2 2023.
• The 5-year median for Change in Cash is -$4.6 million (2025), against an average of $1.8 million.
• Across the five-year window, Change in Cash jumped 2107.68% in 2022 and sank 506.64% in 2023, its largest moves.
• Corcept Therapeutics' Change in Cash stood at $16.1 million in 2022, then soared by 47.65% to $23.8 million in 2023, then tumbled by 140.52% to -$9.6 million in 2024, then soared by 51.76% to -$4.6 million in 2025, then plunged by 153.22% to -$11.8 million in 2026.
• The last three Change in Cash figures came in at -$11.8 million (Q1 2026), -$4.6 million (Q4 2025), and $22.4 million (Q3 2025), per Business Quant data.